UK Vendor Neutral Archive (VNA) & PACS Market (2026-2031)
The UK Vendor Neutral Archive (VNA) & PACS Market was valued at $227.7 Million in 2026 and projected to reach to $369.7 Million by 2031, representing a compound annual growth rate of 10.2%. The UK VNA and PACS market is positioned for sustained growth as NHS trusts and private healthcare providers prioritize digital transformation and operational efficiency.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
UK Vendor Neutral Archive (VNA) & PACS Market Trends and Insights
- The UK healthcare sector is increasingly adopting VNA and PACS solutions to streamline medical imaging workflows, enhance interoperability, and reduce storage costs across NHS trusts and private healthcare providers.
- This 10.2% compound annual growth rate reflects the UK's commitment to digital health transformation and modernizing radiology infrastructure. The UK market is driven by regulatory pressures, aging imaging archives, and the need for vendor-independent solutions that enable seamless data exchange across healthcare networks.
- UK hospitals and diagnostic centers are prioritizing cloud-based and hybrid VNA deployments to improve accessibility and reduce on-premises infrastructure burden.
- The forecast period through 2031 indicates sustained investment in UK healthcare IT, with VNA and PACS solutions becoming central to achieving interoperability mandates and supporting the NHS's long-term digital strategy..
Key Market Statistics
- CAGR (2026-2031) 10.2% CAGR
- Market Size, 2026 ~USD 227.7 Million
- Forecast, 2031 ~USD 369.7 Million
- Country UK
UK Vendor Neutral Archive (VNA) & PACS Market Overview
NHS Digital Transformation :
UK NHS trusts are rapidly modernizing imaging infrastructure through VNA and PACS adoption, driven by the NHS Long Term Plan and digital-first healthcare initiatives to improve patient outcomes and operational efficiency.
Interoperability Mandate :
UK healthcare providers are prioritizing vendor-neutral solutions to break data silos between NHS organizations, private hospitals, and diagnostic centers, enabling seamless image sharing and collaborative care delivery across the healthcare ecosystem.
Cost Optimization Focus :
UK healthcare institutions are leveraging VNA and PACS to reduce expensive on-premise storage infrastructure, lower IT maintenance costs, and optimize capital expenditure through cloud-based and hybrid deployment models.
Regulatory Compliance Drivers :
UK GDPR, NHS Data Security and Protection Toolkit, and Care Quality Commission standards are accelerating VNA adoption as healthcare providers require secure, compliant, and auditable medical imaging management systems.
UK Vendor Neutral Archive (VNA) & PACS Market Dynamics
- Increasing regulatory pressures around data security and interoperability requirements are compelling healthcare organizations to invest in vendor-neutral solutions that enable seamless integration across disparate systems.
- The shift toward cloud-based and hybrid imaging architectures is expected to accelerate adoption, particularly among smaller healthcare facilities seeking cost-effective alternatives to legacy on-premise infrastructure.
- Strategic partnerships between UK healthcare providers and technology vendors will further drive market expansion through tailored solutions addressing NHS-specific workflows and compliance requirements..
Related Ecosystem
Diagnostic Imaging
- Magnetic Resonance Imaging (MRI)
- Computed Tomography (CT)
- CT Scanners
- Nuclear Imaging
- Positron Emission Tomography
- Siemens healthineers
- PHILIPS HEALTHCARE
- CANON INC.
- FUJIFILM Holdings Corporation
- UNITED IMAGING HEALTHCARE CO., LTD.
Healthcare It
- Computed Tomography (CT)
- Machine Learning
- Magnetic Resonance Imaging (MRI)
- Natural Language Processing (NLP)
- Predictive Analytics
- CERNER CORPORATION
- PHILIPS HEALTHCARE
- Oracle Corporation
- GE HealthCare Technologies Inc.
- Siemens healthineers
Key Takeaways
- The UK VNA & PACS market is valued at $227.7 million in 2026 and will reach $369.7 million by 2031, representing a 10.2% CAGR.
- UK healthcare providers are prioritizing vendor-neutral solutions to achieve interoperability and reduce vendor lock-in across NHS and private networks.
- Cloud and hybrid deployment models are gaining traction in the UK market as hospitals seek scalability and reduced capital expenditure.
- Regulatory compliance, data accessibility requirements, and aging legacy systems are key drivers of VNA and PACS adoption across the UK healthcare sector.
Vendor Neutral Archive (VNA) & PACS Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | INDIA (Modality) |
| Forecast Period | 2026–2031 |
| Growth Rate | CAGR of 8.9% from 2026 to 2031 |
| Largest Segment | VNA (Product Type) |
| Market Size Base Year (Billions) | ~USD 5.6 (2026) |
| Revenue Forecast (Billions) | ~USD 8.57 (2031) |
| Segments Covered | Product Type, Modality, Deployment Model, Type, Vendor Type, Application, End User, Type 2023–2030 |
UK Vendor Neutral Archive (VNA) & PACS Market Report Segmentation
8 segment dimensions are covered across the global market.
By Product Type
- Department Vna
- Multi-Department Vna
- Multi-Site Vna
- Pacs
- Vna
By Modality
- Ct
- Mammography
- Mri
- Pet
- Ultrasound
- X-Ray
By Deployment Model
- Cloud-Based Deployment Model
- Cloud-Based Deployment Models
- Hybrid Deployment Models
- On-Premises Deployment Models
By Type
- Department Pacs
- Department Vna
- Multi-Department Pacs
- Multi-Department Vna
- Multi-Site Pacs
- Multi-Site Vna
By Vendor Type
- Independent Vendors
- Third-Party Vendors
By Application
- Cardiology
- Neurology
- Obstetrics & Gynecology
- Oncology
- Orthopedic
- Other Applications
By End User
- Ambulatory Surgery Centers
- Diagnostic Centers
- Hospitals & Clinics
- Other End Users
By Type 2023–2030
- Department Vna
- Multi-Department Vna
- Multi-Site Vna
Target Audience
- NHS Trust IT Directors : Need comprehensive market data to justify VNA and PACS investments to executive leadership, benchmark against peer organizations, and align procurement decisions with NHS digital transformation priorities.
- Healthcare Technology Vendors : Require detailed UK market segmentation, competitive intelligence, and customer insights to develop targeted go-to-market strategies, identify partnership opportunities, and optimize product positioning for NHS and private providers.
- Private Healthcare Operators : Seek market analysis to evaluate VNA and PACS solutions for multi-site imaging networks, understand cost-benefit scenarios, and identify best-in-class vendors meeting UK regulatory and interoperability requirements.
- Healthcare Consultants & Advisors : Need authoritative UK market data and forecasts to advise healthcare organizations on imaging infrastructure modernization, vendor selection, and digital transformation roadmap development.
- Investment & Private Equity Firms : Require market sizing, growth trajectory analysis, and competitive landscape insights to evaluate investment opportunities in UK healthcare IT vendors and assess portfolio company positioning within the VNA and PACS sector.
Key Companies in the UK Vendor Neutral Archive (VNA) & PACS Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| AGFA-GEVAERT GROUP | Belgium | Public Company | Healthcare enterprise imaging platform and software,Diagnostic imaging hardware, X-ray and hardcopy film, and DR equipment,Sign & display and packaging printers, inks, and software, |
| FUJIFILM HOLDINGS CORPORATION | Japan | Public Company | Healthcare (medical systems, CDMO, pharma, regenerative, cosmetics/supplements),Electronics (display, semiconductor, storage, industrial equipment, fine chemicals),Business Innovation (office equipment, document solutions, graphic communications), |
| SECTRA AB | Sweden | Public Company | Imaging IT Solutions (enterprise imaging, PACS/VNA, services),Secure Communications,Business Innovation (orthopedics, medical education, precision diagnostics IT), |
| GE HEALTHCARE | United States | Public Company | Imaging (CT, MR, X-ray, Molecular, Women’s Health),Advanced Visualization Solutions & Ultrasound / Image-Guided Therapies,Patient Care Solutions (Monitoring, Cardiology, Maternal Infant, Anesthesia, Digital), |
| KONINKLIJKE PHILIPS N.V. | Netherlands | Public Company | Diagnosis & Treatment (Imaging and Image-Guided Therapy),Connected Care (Monitoring, Enterprise Informatics, Sleep & Respiratory Care),Personal Health, |
| HYLAND SOFTWARE, INC. | United States | Private Company | OnBase platform (ECM, workflow, case management),Healthcare imaging and interoperability (Hyland Healthcare, Acuo, NilRead, PACSgear, Mackinac),Legacy ECM/BPM suites (Perceptive Content, Perceptive Process, Saperion, NolijWeb), |
| ASPYRA, LLC | United States | Public Company | Laboratory information and workflow solutions,Imaging and orthopedic workflow solutions,Hardware, integration, and professional services, |
AGFA-GEVAERT GROUP
Agfa-Gevaert Group is a Belgian public company established in 1867 with 4,211 employees, operating across imaging and healthcare technology sectors.
FUJIFILM HOLDINGS CORPORATION
Fujifilm Holdings Corporation is a Japanese public company founded in 1934 with 73,526 employees, engaged in imaging, healthcare, and materials technology.
SECTRA AB
Sectra AB is a Swedish public company established in 1957 with 1,365 employees, specializing in medical imaging and cybersecurity solutions.
GE HEALTHCARE
GE Healthcare is a United States-based public company founded in 2022 with 54,000 employees, providing medical imaging and healthcare technology solutions.
KONINKLIJKE PHILIPS N.V.
Koninklijke Philips N.V. is a Dutch multinational public company established in 1891 with 64,317 employees, operating in healthcare, lighting, and consumer electronics.
HYLAND SOFTWARE, INC.
Hyland Software, Inc. is a United States private company established in 1991 with 336 employees, developing content management and workflow automation solutions.
ASPYRA, LLC
Aspyra, LLC is a United States public company founded in 1978 with 70 employees, specializing in healthcare imaging and information management systems.
Reasons to Buy this Report
- NHS-Specific Market Intelligence : Gain detailed insights into NHS trust procurement patterns, digital transformation roadmaps, and budget allocation trends specific to UK healthcare, enabling targeted sales and partnership strategies.
- Competitive Landscape Analysis : Understand UK vendor positioning, market share distribution, and competitive differentiation strategies among leading VNA and PACS providers operating in the British healthcare market.
- Regulatory & Compliance Roadmap : Access comprehensive analysis of UK-specific regulatory drivers including GDPR, NHS Data Security Toolkit, and CQC standards shaping VNA and PACS adoption and implementation requirements.
- Growth Opportunity Identification : Identify high-growth segments within the UK market including NHS acute trusts, private diagnostic centers, and regional health systems with the highest VNA and PACS investment potential.
- Strategic Planning & Forecasting : Leverage accurate 5-year market forecasts (2026-2031) and CAGR projections to inform product development, market entry strategies, and resource allocation decisions for UK healthcare IT initiatives.
Frequently asked questions
What is the current size of the UK VNA & PACS market?
The UK VNA & PACS market is valued at $227.7 million in 2026 and is expected to grow to $369.7 million by 2031.
What is the growth rate of the UK VNA & PACS market?
The UK market is growing at a compound annual growth rate (CAGR) of 10.2% from 2026 to 2031.
Why are UK healthcare providers adopting VNA solutions?
UK providers are adopting VNA solutions to achieve vendor independence, improve interoperability across NHS networks, reduce storage costs, and comply with digital health regulations.
What deployment models are most popular in the UK market?
Cloud-based and hybrid VNA deployments are increasingly popular in the UK as healthcare organizations seek scalability, reduced capital expenditure, and improved data accessibility.
Which sectors drive VNA & PACS adoption in the UK?
NHS trusts, private hospitals, diagnostic imaging centers, and specialty care facilities are the primary drivers of VNA & PACS adoption in the UK healthcare market.
RESEARCH METHODOLOGY
The study involved five major activities to estimate the current size of the VNA & PACS market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for the study of the VNA PACS market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.
Primary Research
Extensive primary research was conducted after acquiring basic knowledge about the VNA & PACS market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (Hospital directors, Hospital Vice Presidents, Department heads, and Critical care specialists ) and supply side (such as C-level and D-level executives, technology experts, product managers, marketing and sales managers, among others) across five major regions North America, Europe, the Asia Pacific, Latin America, Middle East, and Africa. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.
BREAKDOWN OF PRIMARIES
Note 2: Tiers of companies are defined based on their total revenues in 2025. Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the VNA & PACS market. These methods were also used extensively to estimate the size of various subsegments in the market.
Data Triangulation
After arriving at the overall market size using the market size estimation processes, the market was split into several segments and subsegments. To complete the overall market engineering process and determine the exact statistics for each market segment and sub-segment, data triangulation and market breakdown procedures were employed where applicable. The data was triangulated by examining various factors and trends on both the demand and supply sides of the VNA & PACS market.
Market Definition
VNA and PACS are medical imaging technologies that offer cost-effective storage and easy access to images from various modalities. These solutions are essential elements of modern healthcare IT infrastructure, enabling the efficient and secure digitization, storage, retrieval, and sharing of medical imaging data.
Key Stakeholders
- VNA & PACS vendors
- Government bodies
- Healthcare service providers
- Clinical/Physician centers
- Healthcare professionals
- Health IT service providers
- Healthcare associations/institutes
- Ambulatory care centers
- Venture capitalists
- Distributors and resellers
- Maintenance and support service providers
- Integration service providers
- Healthcare players
Report Objectives
- To define, describe, and forecast the VNA & PACS market based on product type, modality, deployment, vendor type, application, end user, and region
- To provide detailed information regarding the factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets¹ with respect to individual growth trends, prospects, and contributions to the market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of market segments in North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile key players and comprehensively analyze their product portfolios, market positions, and core competencies²
- To track and analyze competitive developments such as product launches and approvals; joint ventures, partnerships, & collaborations; acquisitions; and contracts in the VNA & PACS market.
Available customizations:
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
- Product Analysis: Product matrix, which gives a detailed comparison of the product portfolios of each company.
- Geographic Analysis: Further breakdown of Latin America, Europe, and the Middle East & Africa VNA & PACS into specific countries
Get the Full Vendor Neutral Archive (VNA) & PACS Market Report
Full forecast, segment splits, and company analysis for all Vendor Neutral Archive (VNA) & PACS Market.
- US Vendor Neutral Archive (VNA) & PACS Market
- Canada Vendor Neutral Archive (VNA) & PACS Market
- Germany Vendor Neutral Archive (VNA) & PACS Market
- France Vendor Neutral Archive (VNA) & PACS Market
- Italy Vendor Neutral Archive (VNA) & PACS Market
- Spain Vendor Neutral Archive (VNA) & PACS Market
- China Vendor Neutral Archive (VNA) & PACS Market
- Japan Vendor Neutral Archive (VNA) & PACS Market
- India Vendor Neutral Archive (VNA) & PACS Market
- Brazil Vendor Neutral Archive (VNA) & PACS Market
- Mexico Vendor Neutral Archive (VNA) & PACS Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report